🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 8 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
27/06/2018 13,40 13,84 13,20 13,22 -0,75% 4,75% 1.768.600
26/06/2018 13,41 13,54 13,15 13,32 -1,11% 2,91% 1.729.200
25/06/2018 13,00 13,95 12,98 13,47 +1,58% 7,46% 2.073.000
22/06/2018 13,37 13,53 12,99 13,26 +0,61% 4,04% 12.861.600
21/06/2018 13,20 13,47 12,99 13,18 +0,38% 3,64% 1.436.900
20/06/2018 14,10 14,16 12,97 13,13 -6,35% 8,44% 2.140.900
19/06/2018 13,45 14,24 12,80 14,02 +2,11% 10,71% 3.128.000
18/06/2018 11,68 14,00 11,43 13,73 +24,03% 22,00% 5.610.600
15/06/2018 11,60 11,64 11,07 11,07 -4,98% 4,91% 1.970.700
14/06/2018 11,67 11,78 11,15 11,65 -0,09% 5,40% 1.380.900
13/06/2018 11,39 11,84 11,16 11,66 +2,73% 5,98% 1.288.700
12/06/2018 11,17 11,48 11,09 11,35 +2,16% 3,49% 1.223.400
11/06/2018 10,27 11,53 10,12 11,11 +7,76% 13,78% 2.186.000
08/06/2018 10,32 10,40 10,12 10,31 -0,58% 2,71% 1.149.300
07/06/2018 10,75 10,78 9,67 10,37 -2,99% 10,28% 1.718.500
06/06/2018 10,58 10,70 10,49 10,69 +0,75% 1,98% 1.184.500
05/06/2018 10,76 10,95 10,47 10,61 -1,67% 4,46% 1.601.200
04/06/2018 10,99 11,14 10,23 10,79 -1,10% 8,28% 1.551.900
01/06/2018 10,76 11,00 10,62 10,91 +1,77% 3,53% 1.195.900
31/05/2018 11,00 11,57 10,53 10,72 -1,56% 9,45% 3.022.300
30/05/2018 10,40 11,00 10,40 10,89 +5,73% 5,77% 2.797.100
29/05/2018 10,00 10,33 9,96 10,30 +2,49% 3,70% 1.198.100
25/05/2018 9,81 10,18 9,78 10,05 +2,87% 4,08% 1.437.700
24/05/2018 9,79 9,83 9,56 9,77 +0,00% 2,76% 741.500
23/05/2018 9,70 9,94 9,65 9,77 +0,31% 2,99% 744.600
22/05/2018 9,75 10,01 9,58 9,74 -0,31% 4,41% 1.198.900
21/05/2018 10,17 10,35 9,63 9,77 -2,30% 7,08% 1.333.900
18/05/2018 9,66 10,38 9,52 10,00 +4,93% 8,90% 2.105.100
17/05/2018 9,49 9,82 9,44 9,53 +0,21% 4,00% 971.500
16/05/2018 9,56 9,62 9,35 9,51 -0,94% 2,82% 1.280.200